Anne Klibanski

Klibanski studied literature at Barnard College before attaining a medical degree from the Grossman School of Medicine at New York University in 1975.^[4]

She became the chief of the Neuroendocrine unit at Massachusetts General Hospital, studying hormones and neuroendocrinology with a focus in pituitary tumors.^[5] In 1997, Klibanski became the first woman from Mass General's Department of Medicine to become a professor of medicine at Harvard.^[6][7] In 2012, she became Chief Academic Officer at Partners HealthCare in Boston, the first woman to become a chief executive at Massachusetts's largest private employer. She became president and CEO of Mass General Brigham in 2019.^[4][8]

Klibanski serves as Harvard's academic dean for Partners Healthcare System.^[9] In addition to serving as an ex officio member of the board of Mass General Brigham, she sits on the board of directors for Albireo Pharmaceuticals, Partners International, and Crinetics Pharmaceuticals.^[10]

Her compensation as CEO of Mass General Brigham has received press coverage as part of broader discussions on executive compensation in the United States.^[11][12][13]

In January 2026, Klibanski was elected Chair of the Board of Trustees of the Massachusetts Hospital Association (MHA).^[14]

• Prolactin Disorders: From Basic Science to Clinical Management (Springer Publishing, 2019) ISBN 9783030118358
• Neuroendocrine Consequences of Anorexia Nervosa in Adolescents (Chapter 14) of Pediatric Neuroendocrinology (Karger, 2009) ISBN 978-3-8055-9303-8